Journal of Clinical Epidemiology
Volume 56, Issue 11 , Pages 1064-1075 , November 2003

The development and validation of a comorbidity index for prostate cancer among Black men

  • Steven T Fleming

      Affiliations

    • Health Services Management, University of Kentucky, 121 Washington Avenue, Room 113C, Lexington, KY 40536-0003, USA
    • Corresponding Author InformationCorresponding author. Tel.: 859-323-1100; fax: 859-257-2454.
    • ,
  • Kevin A Pearce

      Affiliations

    • Family Practice, University of Kentucky, Rm K-302, Kentucky Clinic, Lexington, KY 40536-0284, USA
    • ,
  • Kathleen McDavid

      Affiliations

    • Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS-K53, Atlanta, GA 30341, USA
    • ,
  • Dmitri Pavlov

      Affiliations

    • Pfizer Inc, Biostatistics & Reporting, MS6025-A3125, 50 Pequot Avenue, New London, CT 06320, USA

,Accepted 20 February 2003.

References 

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin. 2001;51:15–36
  2. Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment following radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993). Urology. 1993;42:622–629
  3. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, et al. Patient-reported symptoms after primary therapy for early prostate cancer. Results of a prospective cohort study. J Clin Oncol. 1998;16:275–283
  4. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg JE. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995;45:1007–1013
  5. Fowler JE, Terrell FL, Renfroe DL. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol. 1996;156(5):1724
  6. Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, et al. Patient reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1997;89:1117–1123
  7. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  8. Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum. 1998;25:685–693
  9. Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll PR. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol. 1998;160:445–448
  10. Stanford JL, Stephenson RA, Coyle LM, Cerhan J, Corea R, Eley JW, et al. Prostate cancer trends 1973–1995, SEER program. NIH Pub. No. 99–4543. Bethesda, MD: National Cancer Institute; 1999;
  11. Yates JW. Comorbidity considerations in geriatric oncology research. CA Cancer J Clin. 2001;51:329–336
  12. Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999;86(1):170–176
  13. Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, et al. Terminal cancer: duration and prediction of survival time. Eur J Cancer. 2000;36:2036–2043
  14. In:  Ries LAG,  Kosary CL,  Hankey BF,  Miller BA,  Harras A,  Edward BK editor. SEER cancer statistics review, 1973–1994. Bethesda (MD): National Cancer Institute; 1997; NIH publication no. 97–2789
  15. Kaplan MH, Feinstein A. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis. 1974;27:387–404
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383
  17. Pompei P, Charlson ME, Douglas G. Clinical assessments as predictors of one year survival after hospitalization: implications for prognostic stratification. J Clin Epidemiol. 1988;41(3):275–284
  18. Pompei P, Charlson ME, Ales K, MacKenzie CR, Norton M. Relating patient characteristics at the time of admission to outcomes of hospitalization. J Clin Epidemiol. 1991;44(10):1063–1069
  19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619
  20. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079
  21. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–1267
  22. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995;274:626–631
  23. Greenfield S, Giovanni A, McNeil BJ, Cleary PD. The importance of co-existant disease in the occurrence of postoperative complications and one-year recovery in patients undegoing total hip replacement. Med Care. 1993;31:141–154
  24. Fleming ST, Dmitrienko A, Rastogi A. A Comprehensive Prognostic Index to predict mortality based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37(6):601–614
  25. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer-related health services research using a linked Medicare tumor registry database. Med Care. 1993;31:732
  26. SAS Institute Inc . SAS/PHREG software, version 8.0. Cary, NC: SAS Institute, Inc; 1999;2000;
  27. Fleming ST, Pearce KA, McDavid K, Pavlov D. 2002 Comorbidity as a predictor of stage of illness for prostate cancer patients under review. J Natl Cancer Inst, in press.
  28. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50(8):939–945
  29. Iezzoni LI. Using administrative diagnostic data to assess the quality of hospital care pitfalls and potential of ICD-9-CM. Int J Technol Assess Health Care. 1990;6:272–281
  30. Jencks SF, Williams DK, Kay TL. Assessing hospital-associated deaths from discharge data. the role of length of stay and comorbidities. JAMA. 1988;260:2240–2246

PII: S0895-4356(03)00213-0

doi: 10.1016/S0895-4356(03)00213-0

Journal of Clinical Epidemiology
Volume 56, Issue 11 , Pages 1064-1075 , November 2003

Article Tools

* Image Usage & Resolution